Vikas Lifecare Limited (IN:VIKASLIFE)
:VIKASLIFE
Want to see IN:VIKASLIFE full AI Analyst Report?
VIKASLIFE Stock Chart & Stats
₹1.80
-₹0.01(-0.24%)
At close: 4:00 PM EST
₹1.80
-₹0.01(-0.24%)
Day’s Range― - ―
52-Week Range₹1.05 - ₹3.15
Previous CloseN/A
Volume3.23M
Average Volume (3M)850.96K
Market Cap
₹2.94B
Enterprise Value₹3.85B
Total Cash (Recent Filing)₹57.31M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)―
Beta1.17
Next Earnings
May 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding1,857,668,600
10 Day Avg. Volume448,294
30 Day Avg. Volume850,962
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)0.87
Price to Sales (P/S)0.96
P/FCF Ratio-1.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthDespite earnings weakness, a strong equity base and a moderate debt-to-equity position provide structural financial resilience. That capital buffer supports supplier credit, inventory financing and gives management time to repair margins or pursue operational fixes without immediate solvency risk.
Diversified Distribution NetworkA trading and distribution model with multi-sector customers and logistics capability is structurally durable. It reduces concentration risk, allows routing of volumes across end markets, and supports scaling when market demand recovers, stabilizing revenue sources over months.
Positive Revenue TrendReported ~9% revenue growth shows consistent top-line expansion despite margin pressure. Sustained volume or mix growth indicates underlying demand for polymer and chemical inputs, giving management runway to tackle cost structure and convert sales momentum into improved profitability.
Bears Say
Negative ProfitabilityNet losses and weakened gross/EBIT/EBITDA margins signal persistent operational issues. Negative profitability erodes retained earnings, limits reinvestment, and undermines returns metrics; without margin recovery the core trading model may struggle to sustain growth or absorb cost shocks.
Weak Cash GenerationNegative operating and free cash flow point to structural liquidity stress: higher working capital needs, inventories or receivables are tying up funds. Continued weak cash generation increases reliance on external financing and constrains investment in logistics or supplier terms.
Rising Debt LevelsAn increase in debt amid negative earnings and poor cash flow raises refinancing and interest coverage risk. Higher leverage reduces financial flexibility, making the company more vulnerable to cost increases or slower collections and potentially raising funding costs over the medium term.
Vikas Lifecare Limited News
VIKASLIFE FAQ
What was Vikas Lifecare Limited’s price range in the past 12 months?
Vikas Lifecare Limited lowest stock price was ₹1.05 and its highest was ₹3.15 in the past 12 months.
What is Vikas Lifecare Limited’s market cap?
Vikas Lifecare Limited’s market cap is ₹2.94B.
When is Vikas Lifecare Limited’s upcoming earnings report date?
Vikas Lifecare Limited’s upcoming earnings report date is May 21, 2026 which is in 20 days.
How were Vikas Lifecare Limited’s earnings last quarter?
Vikas Lifecare Limited released its earnings results on Feb 07, 2026. The company reported -₹0.157 earnings per share for the quarter, missing the consensus estimate of N/A by -₹0.157.
Is Vikas Lifecare Limited overvalued?
According to Wall Street analysts Vikas Lifecare Limited’s price is currently Overvalued.
Does Vikas Lifecare Limited pay dividends?
Vikas Lifecare Limited does not currently pay dividends.
What is Vikas Lifecare Limited’s EPS estimate?
Vikas Lifecare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vikas Lifecare Limited have?
Vikas Lifecare Limited has 1,857,668,600 shares outstanding.
What happened to Vikas Lifecare Limited’s price movement after its last earnings report?
Vikas Lifecare Limited reported an EPS of -₹0.157 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.485%.
Which hedge fund is a major shareholder of Vikas Lifecare Limited?
Currently, no hedge funds are holding shares in IN:VIKASLIFE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vikas Lifecare Limited
Vikas Lifecare Limited engages in the trading of various chemicals compounds, polymers, PVC resins, plastic granules, and products related to plastic industry in India. It operates through Real Estate, Trading- Polymers, Trading-Cashew Nuts, and Manufacturing divisions. The company is also involved in the real estate business; and the manufacture of recycled material for automotive, packaging, sheathing, and textile industries. In addition, it manufactures and sells polymer compounds, which include PE, PVC, V blend SOE, and polypropylene compounds, as well as thermo plastic rubber; deals in FMCG, cashew nuts, aluminum foils, and processed food products. Vikas Lifecare Limited also exports its products. The company was formerly known as Vikas Multicorp Limited and changed its name to Vikas Lifecare Limited in April 2021. Vikas Lifecare Limited was incorporated in 1995 and is based in New Delhi, India.
Technical Analysis
Albert David Ltd
―
Lyka Labs Limited
―
Medicamen Biotech Limited
―
Nectar Lifesciences Ltd.
―
Zim Laboratories Ltd.
―